Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Velcade + Gemcitabine + Cisplatin in Advanced NSCLC
NCT01633645Phase 2Completed
- Sponsor
- University Hospital of Crete
- Start
- Jun 2009
- Primary completion
- Apr 2013
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of bortezomib in non-small cell lung cancer (NSCLC), sponsored by University Hospital of Crete. Started Jun 2009; status: completed.
02
Drugs
bortezomib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01633645.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01633645.